Results 31 to 40 of about 24,217 (252)

Survey of Microsurgery Training Availability in US Urology Residency Programs

The World Journal of Men's Health, 2021
Purpose: The Accreditation Council of Graduate Medical Education (ACGME) establishes surgical minimum numbers of cases for urologic training. Currently there is not a requirement for microsurgery, likely from a belief that programs do not offer ...
Thomas A. Masterson, Sirpi Nackeeran, Quinn Rainer, Nicholas Hauser, Robert Marcovich, Ranjith Ramasamy   +5 more
doaj   +1 more source

I CONGRESS OF THE CHILDREN’S URINOLOGISTS AND ANDROLOGISTS

Педиатрическая фармакология, 2009
The Ist Congress of specialists in pediatric urology and andrology was orginised by Interregional public organization of pediatric urology and andrology (IPOPUA) and held in Moscow December 12-13, 2008.
S.N. Zorkin
doaj   +2 more sources

The Andrology Working Group of the Society of Urological Surgery in Turkiye: Bridging Academic Gaps and Advancing Male Reproductive or Sexual Health

Journal of Urological Surgery
The Andrology Working Group of the Society of Urological Surgery in Turkiye was established to address the lack of a formal andrology subspecialty in Turkiye and to advance male reproductive and sexual health.
Gökhan Çeker, Hasan Deliktaş, Ümit Gül, Tahsin Turunç, The Andrology Working Group of the Society of Urological Surgery in Turkiye   +4 more
doaj   +1 more source

A Schematic Overview of the Current Status of Male Infertility Practice

The World Journal of Men's Health, 2020
The practice of male infertility has dramatically evolved over the past few decades. This has been achieved after the realization of the important contribution the male counterpart holds in the couple’s infertility.
Ashok Agarwal, Ahmad Majzoub, Neel Parekh, Ralf Henkel   +3 more
doaj   +1 more source

From Azoospermia to Fertility: A Successful Case of mTESE Treatment

Liječnički vjesnik, 2023
Infertility is diagnosed clinically in heterosexual couples who cannot achieve pregnancy after a year of having intercourse without using birth control.
Lara Fotez, Martin Bobek, Klara Dorešić, Lucija Fotez, Dinko Hauptman   +4 more
doaj   +1 more source

Real‐World Clinical Evaluation of S2,3PSA Test in a Prostate Biopsy Cohort With PSA Level of 4–10 ng/mL

The Prostate, EarlyView.
ABSTRACT Background Prostate‐specific antigen (PSA) is a widely used prostate cancer marker; however, its use is limited by its low specificity. Novel biomarkers are being explored to avoid unnecessary biopsies. A new prostate cancer marker, S2,3PSA, became eligible for insurance coverage in February 2024.
Jun Furumido, Sho Nonoyama, Chika Hoshi (Hosokawa), Shogo Aizawa, Nariaki Ozaki, Takuto Morita, Akihiro Yamashita, Issei Tsunemi, Ryo Kato, Kanta Hori, Naohiko Shimoda   +10 more
wiley   +1 more source

Androgenic‐anabolic steroid abuse trend and management: A prospective, cross‐sectional, questionnaire‐based survey

Health Science Reports, 2023
Background and Aims Androgenic‐anabolic steroid (AAS) abuse is a global health concern, studies revealing an increasing trend of abuse and deleterious effects on reproductive health.
Manaf Al Hashimi, Yasser Farahat, Hussein Kandil, Ismail Al Khalidi   +3 more
doaj   +1 more source

Prognostic Role of Serum Neuron‐Specific Enolase at Baseline and its Early Dynamics in Metastatic Castration‐Resistant Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors

The Prostate, EarlyView.
ABSTRACT Background Outcomes of metastatic castration‐resistant prostate cancer (mCRPC) treated with androgen receptor signaling inhibitors (ARSIs) vary widely and may not be fully reflected by PSA and standard clinicopathologic factors. We evaluated the prognostic value of serum neuron‐specific enolase (NSE) at baseline and early on‐treatment dynamics.
Ondřej Fiala, Michaela Tkadlecová, Zuzana Váchalová, Milan Hora, Jan Králíček, Petr Stránský Jr., Václav Liška, Matteo Santoni, Giuseppe Luigi Banna, Kristýna Pivovarčíková, Ondřej Topolčan, Jindřich Fínek   +11 more
wiley   +1 more source

Spatial Distribution of Prostate Cancer Missed by MRI‐Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort

The Prostate, EarlyView.
ABSTRACT Purpose Systematic biopsy (SB) remains recommended in addition to MRI‐targeted biopsy (TB) because TB alone may miss clinically significant prostate cancer (sPC). We evaluated the spatial distribution of sPC and clinically insignificant prostate cancer (iPC) detected by SB in relation to MRI lesions and assessed the effect of perilesional ...
Ruth Himmelsbach, Julia Franz, Cordula Jilg, Christian Gratzke, August Sigle   +4 more
wiley   +1 more source

Efficacy, Safety, and Cost‐Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer: A Multicenter Retrospective Study

The Prostate, EarlyView.
ABSTRACT Background The introduction of novel androgen receptor signaling inhibitors (ARSIs) has substantially transformed the systemic treatment landscape for non‐metastatic castration‐resistant prostate cancer (nmCRPC). Unfortunately, ARSI therapy is associated with considerable adverse events (AEs) and high medical costs.
Himawari Asanuma, Naoki Fujita, Shumon Kato, Yohei Kawashima, Masanao Shinohara, Ryuji Tabata, Fumiya Yoneyama, Ryuma Tanaka, Takuya Oishi, Hikari Miura, Kyo Togashi, Kazutaka Okita, Hirotaka Horiguchi, Toshikazu Tanaka, Daisuke Noro, Yuichiro Suzuki, Satoshi Sato, Chikara Ohyama, Shingo Hatakeyama   +18 more
wiley   +1 more source